RecruitingNCT07343271

Dual-energy CT vs. MRI in the Evaluation of Squamous Cell Carcinomas of the Oral Cavity and Oropharynx


Sponsor

University Hospital, Strasbourg, France

Enrollment

30 participants

Start Date

Jul 11, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The diagnostic and pre-therapeutic assessment of squamous cell carcinomas requires a neck and chest CT scan and a neck and facial MRI, which is the most effective examination, to establish the TNM stage of the tumor. However, obtaining this complete assessment can delay treatment. Confirmation of the non-inferiority of 40keV dual-energy CT in BOLT compared to MRI would spare the patient an additional MRI examination, speed up the pre-treatment assessment, reduce the loss of opportunity due to delayed treatment, and free up MRI imaging slots, which are still insufficient in the region.


Eligibility

Min Age: 18 Years

Inclusion Criteria5

  • Adult patient (≥18 years)
  • presenting with oral or oropharyngeal squamous cell carcinoma proven by histopathological analysis of a biopsy
  • having undergone a clinical examination with nasofibroscopy by an ENT surgeon specializing in cancer surgery
  • a contrast-enhanced cervicofacial MRI
  • and a contrast-enhanced cervicofacial DECT with BOLT maneuver.

Exclusion Criteria3

  • A lesion other than oral or oropharyngeal squamous cell carcinoma
  • A labial location
  • A contraindication to performing one or both of the imaging examinations.

Locations(1)

Service d'ORL et de Chirurgie Cervico-faciale - CHU de Strasbourg - France

Strasbourg, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07343271


Related Trials